M89.49
Other hypertrophic osteoarthropathy, multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Other hypertrophic osteoarthropathy, classified under ICD-10 code M89.49, is a medical condition characterized by abnormal proliferation of the bones and skin at multiple sites. It often presents with swelling, joint pain, and changes in the appearance of the affected areas. This condition can be associated with underlying diseases, particularly those involving the lungs or other internal organs. While it can occur sporadically, hypertrophic osteoarthropathy is frequently linked to secondary causes, making thorough evaluation important for proper management.
Causes & Symptoms
Clinical Causes: Underlying lung diseases such as lung cancer, pneumonia, or bronchiectasis Other internal malignancies, especially those involving the gastrointestinal tract Chronic infections or inflammatory conditions affecting the thoracic cavity Genetic predispositions or idiopathic cases where no clear cause is identified Certain heart or vascular diseases
Key Symptoms: Swelling of the distal parts of the limbs, especially fingers and toes Joint pain and stiffness affecting multiple sites Thickening of the skin over affected areas Clubbing of the fingers and toes, leading to a rounded and enlarged appearance Pain that worsens with activity or movement Reduced range of motion in affected joints Possible redness or warmth over swollen areas
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical evaluation, radiographic imaging, and medical history review. Physicians may perform:
Treatment Protocols: Treatment strategies aim to manage symptoms and address underlying causes:
Clinical Advice & FAQs
Billing Guidance
Is M89.49 a billable ICD-10 code?
Yes, M89.49 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M89.49?
Clinical documentation must specify the nature of Other hypertrophic osteoarthropathy, multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference